drugset / Trial / NCT00896831

Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy

NCT00896831

Phase 4 Unknown 96 enrolled Hospital de Clinicas de Porto Alegre
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study aimed to assess the effectiveness and safety of L-ornithine-L-aspartate in the management of hepatic encephalopathy.

Timeline

Start
2008-11
Primary completion
2010-03
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator L-ornithine L-aspartate Other / unclassified 5 g